Volume 12, Issue 6, Pages (June 2000)

Slides:



Advertisements
Similar presentations
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Advertisements

Volume 14, Issue 6, Pages (June 2001)
Volume 7, Issue 5, Pages (November 1997)
W. L. Parker, M. D. , Ph. D. , K. W. Finnson, Ph. D. , H. Soe-Lin, B
Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma.
Volume 9, Issue 5, Pages (November 1998)
Volume 129, Issue 2, Pages (August 2005)
Monomeric and Oligomeric Complexes of the B Cell Antigen Receptor
Adenosine-induced apoptosis in glomerular mesangial cells
A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils by Barbara Geering, Ursina Gurzeler, Elena Federzoni, Thomas Kaufmann,
Regulation of Mast Cell Survival by IgE
Volume 7, Issue 6, Pages (December 1997)
Volume 23, Issue 6, Pages (December 2005)
Volume 47, Issue 2, Pages (July 2012)
Compartmentalization of TNF Receptor 1 Signaling
Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels  R. Ahmad, M. El.
Volume 54, Issue 6, Pages (June 2014)
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Volume 4, Issue 4, Pages (April 1996)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 13, Issue 10, Pages (December 2015)
Enhanced Death Ligand-Induced Apoptosis in Cutaneous SCC Cells by Treatment with Diclofenac/Hyaluronic Acid Correlates with Downregulation of c-FLIP 
Bonnie N Dittel, IrenaŠtefanova, Ronald N Germain, Charles A Janeway 
Volume 24, Issue 5, Pages (May 2006)
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Monika Raab, Antonio J.da Silva, Paul R. Findell, Christopher E. Rudd 
SUMO Signaling by Hypoxic Inactivation of SUMO-Specific Isopeptidases
Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma.
Volume 20, Issue 4, Pages (April 2004)
Volume 4, Issue 2, Pages (February 1996)
Volume 6, Issue 6, Pages (December 2000)
Regulation of Mast Cell Survival by IgE
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
TNF-Induced Activation of the Nox1 NADPH Oxidase and Its Role in the Induction of Necrotic Cell Death  You-Sun Kim, Michael J. Morgan, Swati Choksi, Zheng-gang.
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin  Y. Luan, Ph.D., M.D., L. Kong, Ph.D.,
Volume 18, Issue 5, Pages (May 2003)
Olivier Micheau, Jürg Tschopp  Cell 
p53 stabilization is decreased upon NFκB activation
Volume 56, Issue 5, Pages (December 2014)
Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro- inflammatory “FADDosome” Complex upon TRAIL Stimulation  Conor M. Henry, Seamus.
Volume 8, Issue 9, Pages S1-S2 (April 1998)
Resistance of Human Melanoma Cells Against the Death Ligand TRAIL Is Reversed by Ultraviolet-B Radiation via Downregulation of FLIP  Elke Zeise, Michael.
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Volume 17, Issue 2, Pages (August 1996)
Volume 103, Issue 6, Pages (December 2000)
Negative Selection of Immature B Cells by Receptor Editing or Deletion Is Determined by Site of Antigen Encounter  Peter C Sandel, John G Monroe  Immunity 
Volume 43, Issue 3, Pages (August 2011)
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
tRNA Binds to Cytochrome c and Inhibits Caspase Activation
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Silva H Hanissian, Raif S Geha  Immunity 
Lindsey A. Allan, Paul R. Clarke  Molecular Cell 
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Anu Cherukuri, Paul C. Cheng, Hae Won Sohn, Susan K. Pierce  Immunity 
The TNF Receptor 1 Cell Volume 114, Issue 2, Pages (July 2003)
The CD28 Signaling Pathway Regulates Glucose Metabolism
Volume 7, Issue 4, Pages (October 1997)
Volume 11, Issue 3, Pages (September 1999)
Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase  Parameswaran Ramakrishnan,
Volume 4, Issue 4, Pages (October 1999)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Volume 23, Issue 2, Pages (August 2005)
Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho  Aron B. Jaffe, Alan Hall, Anja Schmidt 
Volume 15, Issue 2, Pages (August 2001)
Volume 41, Issue 4, Pages (February 2011)
Volume 86, Issue 5, Pages (September 1996)
Volume 17, Issue 5, Pages (March 2007)
Volume 14, Issue 6, Pages (June 2001)
Volume 24, Issue 3, Pages (March 2006)
Presentation transcript:

Volume 12, Issue 6, Pages 611-620 (June 2000) Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5  Frank C Kischkel, David A Lawrence, Anan Chuntharapai, Peter Schow, K.Jin Kim, Avi Ashkenazi  Immunity  Volume 12, Issue 6, Pages 611-620 (June 2000) DOI: 10.1016/S1074-7613(00)80212-5

Figure 1 The B Lymphoma Cell Line BJAB Expresses DR4 and DR5 and Is Sensitive toward Apo2L/TRAIL-Induced Apoptosis (A) BJAB cells were stained with antireceptor mAbs and analyzed by flow cytometry. Thin and thick lines show staining patterns of background and indicated antibody, respectively. Data are representative of three independent experiments. (B) Characterization of endogenous DR4 and DR5. Immunoprecipitations (IP) with a control (Crtl IgG) and receptor-selective mAbs are shown. The IPs were resolved by SDS-PAGE and analyzed by Western blotting (WB) with the indicated antibody. (C) Cells were incubated with 2 μg/ml anti-Flag (M2) mAb and various concentrations of Flag-tagged ligand for 24 hr and analyzed for apoptosis. Data are means ± SD of triplicates. Immunity 2000 12, 611-620DOI: (10.1016/S1074-7613(00)80212-5)

Figure 2 Apo2L/TRAIL Recruits DR4, DR5, FADD, and Caspase-8 into the DISC in BJAB Cells Ligands (1 μg/ml) plus M2 mAb (2 μg/ml) were added either after cell lysis (unstimulated) or 10 min before cell lysis (stimulated). (A) IP of DR4 or DR5 through Apo2L/TRAIL. Each receptor was visualized by WB. (B) Characterization of DR4 and DR5 by direct IP and 2D gel/WB analysis. (C–F) 2D gel analysis of the Apo2L/TRAIL and FasL DISC by metabolic labeling (C and D) and subsequent WB (E and F). White arrowhead pairs indicate 35S-labeled pro-caspase-8 isoforms (p55/53, upper doublet) and FADD (lower doublet). Black arrows mark the corresponding doublets of spots in the WB analysis. Gray arrows indicate the processed forms of caspase-8 (p43/41). White boxes surround 35S-labeled DR4 and DR5 spot areas. Immunity 2000 12, 611-620DOI: (10.1016/S1074-7613(00)80212-5)

Figure 3 Apo2L/TRAIL Does Not Recruit Endogenous TRADD or RIP in BJAB Cells RIP, TRADD, or FADD in BJAB cell lysates were detected either by IP/WB (two left lanes) or by direct WB (last lane on right). Apo2L/TRAIL-Flag or FasL-Flag (1 μg/ml) plus M2 (2 μg/ml), or TNF (0.1 μg/ml) were added as indicated for 0, 10, or 60 min, and the cells were lysed and DISCs analyzed by IP with anti-TNFR1 for TNF or through M2 for Apo2L/TRAIL or FasL. Signaling components in the IPs were visualized by WB. Immunity 2000 12, 611-620DOI: (10.1016/S1074-7613(00)80212-5)

Figure 4 Apo2L/TRAIL Recruits FADD and Caspase-8 in Multiple Cell Lines (A) Expression of DR4, DR5, DcR1, and DcR2 as analyzed by flow cytometry. Data are means ± SD of duplicates, and represent at least two independent experiments. Specific mean fluorescence was determined by subtraction of background fluorescence as measured with secondary antibody alone. (B) Apoptosis induction. Cells were incubated with 1 μg/ml Apo2L/TRAIL-Flag + 2 μg/ml M2 for 24 hr and then analyzed for apoptosis in triplicates. (C) One-dimensional Apo2L/TRAIL DISC analysis. Cells were incubated with Apo2L/TRAIL-Flag (1 μg/ml) plus M2 (2 μg/ml) for 0, 10, or 60 min, lysed, and subjected to IP through M2 and WB analysis. Immunity 2000 12, 611-620DOI: (10.1016/S1074-7613(00)80212-5)

Figure 5 DR4 and DR5 Can Form Heteromeric Complexes, but Each Can Recruit FADD and Caspase-8 Independently of the Other (A) Ligand-dependent formation of receptor heterocomplexes in BJAB cells. Cells were stimulated with 1 μg/ml Apo2L/TRAIL-Flag for 10 min (+) or left untreated (−). DR4 and DR5 were captured by IP with nonblocking (4G7 and 5C7, respectively) or blocking (1H5 and 3F11, respectively) mAb and visualized by WB analysis. (B) G55 and G142 cells express DR5 but not DR4, DcR1, or DcR2. Cells by flow cytometry as in Figure 1. The data is representative of three independent experiments. (C) Apo2L/TRAIL induces apoptosis in G55 and G142 cells. Cells were treated and analyzed as in Figure 4B. (D) Apo2L/TRAIL stimulates recruitment of FADD and caspase-8 through DR5. Cells were treated and analyzed as in Figure 4C. (E) Fc-cross-linked anti-DR4 or anti-DR5 mAbs induce apoptosis in BJAB cells. Cells were incubated with DR4 (4H6) or DR5 (3F11) mAb or both mAbs (1 μg/ml) plus anti-Fc antibody (0.5 μg/ml), or Apo2L/TRAIL-Flag (1 μg/ml) plus M2 (2 μg/ml) for 24 hr and analyzed for apoptosis. (F) DR4 cross-linking recruits FADD and caspase-8. BJAB cells were treated with cross-linked DR4 mAb (5 × 107 cells per lane) or Apo2L/TRAIL-Flag plus M2 (1 × 107 cells per lane) as in (E) either after (−) or 10 min before (+) cell lysis. Lysates were subjected to IP with protein A/G beads and WB analysis with the indicated antibodies. Immunity 2000 12, 611-620DOI: (10.1016/S1074-7613(00)80212-5)